{
    "SPADE_N_14669": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14669",
            "Peptide Name": "Cath-LW-0 (Predicted AMPs, Arg-rich, UCLL1)",
            "Source": "Sea Seal,Leptonychotes weddellii",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "KRFGRLRDLIRRGRQKIGRRINRLGRRIQDILKNLQPGKVS",
            "Sequence Length": 41,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 4938.84,
            "PI": 12.0,
            "Hydrophobicity": -1.11,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Li J, Xiong W, Yang J, Liao W, Gao Y, Chai J, Wu J, Liu S, Xu X.2025",
                    "Reference": "Biochem Pharmacol. 2025 Mar 25;236:116891. doi: 10.1016/j.bcp.2025.116891.PubMed",
                    "Title": "Characterization of the first antimicrobial peptide from Sea Seal with potent therapeutic effect in septic mice."
                }
            ],
            "Frequent Amino Acids": "RGI",
            "Absent Amino Acids": "ACEHMOTUWY",
            "Basic Residues": 15,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 13,
            "Polar Residues": 22,
            "Positive Residues": 15,
            "Negative Residues": 2,
            "Net Charge": 13,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (90.24%) toCATH-LWR: 27%, L=G: 12%. As another possible cleaved peptide, Cath-LW-0 has 4 extra N-terminal residues than Cath-LW. Which form is natural remains to be confirmed.Activity: Active against Gram- E. coli (data not shown). other bacteria not tested.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_14668",
                    "Similarity": 1.0,
                    "Sequence": "RLRDLIRRGRQKIGRRINRLGRRIQDILKNLQPGKVS"
                },
                {
                    "SPADE_ID": "SPADE_UN_12465",
                    "Similarity": 0.625,
                    "Sequence": "RGRKGRRRGRKGRRKK"
                },
                {
                    "SPADE_ID": "SPADE_N_04421",
                    "Similarity": 0.6060606060606061,
                    "Sequence": "RLKELITTGGQKIGEKIRRIGQRIKDFFKNLQP"
                }
            ]
        }
    }
}